The influence of HLA matching in cardiac allograft recipients receiving cyclosporine and azathioprine.
Yacoub
M
M
Harefield Hospital, Middlesex, England.
Festenstein
H
H
Doyle
P
P
Martin
M
M
McCloskey
D
D
Awad
J
J
Gamba
A
A
Khaghani
A
A
Holmes
J
J
D001379:Azathioprine / Q000627:therapeutic use*; D001788:Blood Grouping and Crossmatching; D003524:Cyclosporins / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000032:analysis; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D006650:Histocompatibility Testing; D006801:Humans; D014184:Transplantation, Homologous
D003524:Cyclosporins; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D001379:Azathioprine